Literature DB >> 9321765

Homozygosity for the predominant Cys282Tyr mutation and absence of disease expression in hereditary haemochromatosis.

D A Rhodes1, R Raha-Chowdhury, T M Cox, J Trowsdale.   

Abstract

A candidate gene for hereditary haemochromatosis, HLA-H, has recently been presented. Two missense mutations in the HLA-H gene sequence are predicted to account for nearly 90% of all cases of the disease. The aim of this study was to correlate the presence of these missense mutations with the expressivity of the disease, as assessed by standard biochemical evaluation of serum iron parameters. Detection of the known mutations in haemochromatosis, Cys282Tyr and His63Asp, was undertaken in a large pedigree showing variable expression of the disease in successive generations. In three sibs with overt disease (one male, two female, aged 50 to 53 years), homozygosity for the predominant G to A transition (Cys282Tyr) in HLA-H was detected. However, homozygosity for this mutation was also detected in an asymptomatic male sib, aged 50, harbouring an identical genotype. The finding of an asymptomatic homozygous Cys282Tyr subject, haplo-identical to affected sibs, indicates that clinical expression of symptomatic disease is variable, even in middle aged Cys282Tyr homozygotes. This has profound implications for the future use of genetic screening for haemochromatosis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9321765      PMCID: PMC1051063          DOI: 10.1136/jmg.34.9.761

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  19 in total

1.  A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis.

Authors:  J N Feder; A Gnirke; W Thomas; Z Tsuchihashi; D A Ruddy; A Basava; F Dormishian; R Domingo; M C Ellis; A Fullan; L M Hinton; N L Jones; B E Kimmel; G S Kronmal; P Lauer; V K Lee; D B Loeb; F A Mapa; E McClelland; N C Meyer; G A Mintier; N Moeller; T Moore; E Morikang; C E Prass; L Quintana; S M Starnes; R C Schatzman; K J Brunke; D T Drayna; N J Risch; B R Bacon; R K Wolff
Journal:  Nat Genet       Date:  1996-08       Impact factor: 38.330

2.  Haemochromatosis and HLA-H.

Authors:  E C Jazwinska; L M Cullen; F Busfield; W R Pyper; S I Webb; L W Powell; C P Morris; T P Walsh
Journal:  Nat Genet       Date:  1996-11       Impact factor: 38.330

3.  Diagnosis of hemochromatosis in young subjects: predictive accuracy of biochemical screening tests.

Authors:  M L Bassett; J W Halliday; R A Ferris; L W Powell
Journal:  Gastroenterology       Date:  1984-09       Impact factor: 22.682

4.  Survival and causes of death in cirrhotic and in noncirrhotic patients with primary hemochromatosis.

Authors:  C Niederau; R Fischer; A Sonnenberg; W Stremmel; H J Trampisch; G Strohmeyer
Journal:  N Engl J Med       Date:  1985-11-14       Impact factor: 91.245

5.  Concordance of iron storage in siblings with genetic hemochromatosis: evidence for a predominantly genetic effect on iron storage.

Authors:  D H Crawford; J W Halliday; K M Summers; M J Bourke; L W Powell
Journal:  Hepatology       Date:  1993-05       Impact factor: 17.425

6.  Mutation analysis in hereditary hemochromatosis.

Authors:  E Beutler; T Gelbart; C West; P Lee; M Adams; R Blackstone; P Pockros; M Kosty; C P Venditti; P D Phatak; N K Seese; K A Chorney; A E Ten Elshof; G S Gerhard; M Chorney
Journal:  Blood Cells Mol Dis       Date:  1996       Impact factor: 3.039

7.  Evidence for heterogeneity in hereditary hemochromatosis. Evaluation of 174 persons in nine families.

Authors:  W A Muir; G D McLaren; W Braun; A Askari
Journal:  Am J Med       Date:  1984-05       Impact factor: 4.965

8.  Hereditary hemochromatosis. Analysis of laboratory expression of the disease by genotype in 18 pedigrees.

Authors:  M M Dadone; J P Kushner; C Q Edwards; D T Bishop; M H Skolnick
Journal:  Am J Clin Pathol       Date:  1982-08       Impact factor: 2.493

9.  Haplotype analysis in Australian hemochromatosis patients: evidence for a predominant ancestral haplotype exclusively associated with hemochromatosis.

Authors:  E C Jazwinska; W R Pyper; M J Burt; J L Francis; S Goldwurm; S I Webb; S C Lee; J W Halliday; L W Powell
Journal:  Am J Hum Genet       Date:  1995-02       Impact factor: 11.025

10.  New polymorphic microsatellite markers place the haemochromatosis gene telomeric to D6S105.

Authors:  R Raha-Chowdhury; D J Bowen; C Stone; J J Pointon; J D Terwilliger; J D Shearman; K J Robson; A Bomford; M Worwood
Journal:  Hum Mol Genet       Date:  1995-10       Impact factor: 6.150

View more
  13 in total

1.  Variable phenotypic presentation of iron overload in H63D homozygotes: are genetic modifiers the cause?

Authors:  P Aguilar-Martinez; M Bismuth; M C Picot; C Thelcide; G P Pageaux; F Blanc; P Blanc; J F Schved; D Larrey
Journal:  Gut       Date:  2001-06       Impact factor: 23.059

2.  The Southern French registry of genetic hemochromatosis: a tool for determining clinical prevalence of the disorder and genotype penetrance.

Authors:  Patricia Aguilar-Martinez; Michael Bismuth; François Blanc; Pierre Blanc; Severine Cunat; Olivier Dereure; Pierre Dujols; Muriel Giansily-Blaizot; Christian Jorgensen; Amadou Konate; Dominique Larrey; Alain Le Quellec; Thibault Mura; Isabelle Raingeard; Jeanne Ramos; Eric Renard; Florence Rousseau; Jean-François Schved; Marie-Christine Picot
Journal:  Haematologica       Date:  2010-02-09       Impact factor: 9.941

3.  Lack of clinical manifestation of hereditary haemochromatosis in South African patients with multiple sclerosis.

Authors:  Maritha J Kotze; J Nico P de Villiers; Louise Warnich; Stephen Schmidt; Jonathan Carr; Erna Mansvelt; Elba Fourie; Susan J van Rensburg
Journal:  Metab Brain Dis       Date:  2006-07-19       Impact factor: 3.584

4.  HFE gene mutation (C282Y) and phenotypic expression among a hospitalised population in a high prevalence area of haemochromatosis.

Authors:  S Distante; J P Berg; K Lande; E Haug; H Bell
Journal:  Gut       Date:  2000-10       Impact factor: 23.059

5.  Classification and genetic features of neonatal haemochromatosis: a study of 27 affected pedigrees and molecular analysis of genes implicated in iron metabolism.

Authors:  A L Kelly; P W Lunt; F Rodrigues; P J Berry; D M Flynn; P J McKiernan; D A Kelly; G Mieli-Vergani; T M Cox
Journal:  J Med Genet       Date:  2001-09       Impact factor: 6.318

6.  Analysis of genes implicated in iron regulation in individuals presenting with primary iron overload.

Authors:  Monique G Zaahl; Alison T Merryweather-Clarke; Maritha J Kotze; Schalk van der Merwe; Louise Warnich; Kathryn J H Robson
Journal:  Hum Genet       Date:  2004-08-24       Impact factor: 4.132

7.  Non-C282Y familial iron overload: evidence for locus heterogeneity in haemochromatosis.

Authors:  S Pinson; J Yaouanq; A M Jouanolle; B Turlin; H Plauchu
Journal:  J Med Genet       Date:  1998-11       Impact factor: 6.318

8.  The 16189 variant of mitochondrial DNA occurs more frequently in C282Y homozygotes with haemochromatosis than those without iron loading.

Authors:  K J Livesey; V L C Wimhurst; K Carter; M Worwood; E Cadet; J Rochette; A G Roberts; J J Pointon; A T Merryweather-Clarke; M L Bassett; A-M Jouanolle; A Mosser; V David; J Poulton; K J H Robson
Journal:  J Med Genet       Date:  2004-01       Impact factor: 6.318

Review 9.  Maternal Iron Status in Pregnancy and Long-Term Health Outcomes in the Offspring.

Authors:  Nisreen A Alwan; Hanan Hamamy
Journal:  J Pediatr Genet       Date:  2015-06

10.  Exploring the relationship between maternal iron status and offspring's blood pressure and adiposity: a Mendelian randomization study.

Authors:  Nisreen A Alwan; Debbie A Lawlor; Harry J McArdle; Darren C Greenwood; Janet E Cade
Journal:  Clin Epidemiol       Date:  2012-08-09       Impact factor: 4.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.